NCT00604500View on ClinicalTrials.gov

A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1)

PHASE3CompletedINTERVENTIONAL

Enrollment

272

Participants

Timeline

Start Date

March 1, 2008

Primary Completion Date

November 1, 2008

Study Completion Date

November 1, 2008

Conditions

AsthmaCOPD

Interventions

DRUG

SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F )

MF/F MDI 100/10 mcg BID with an integrated dose counter (administered as two inhalations of MF/F MDI 50/5 mcg, twice a day) over a 4-week Treatment Period.